Basic info
Industry
biotechnology research
Sectors
Biotechnology
immune response
preclinical
immune markers
immunotox
immunology
immune modelling
immunogenicity
mass spectrometry
Health Care
tissue damage
mathematical modelling
human cells
flow cytometry
protein biology
in vivo
cell culture
cell characterisation
in vitro
disease mechanisms
immunohistochemistry
Date founded
2016
Funding rounds raised
Total raised
$82K
from 1 investors over 1 rounds
I
Immundnz Ltd raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)